• A Sequencing Squabble over Ion Torrent’s Stanford Licenses

    Jul 20, 2011, 13:55 PM by Michael Croft
    Bio-IT World | As Ion Torrent publishes details of its destop sequencing technology in Nature this week, charges continue to fly over the intellectual credit for some of the key technology that Ion Torrent exclusively licensed from Stanford University’s Office of Technology Licensing.  
    Full story

  • Drug Discovery with Computational Chemistry

    Jul 20, 2011, 00:00 AM by Michael Croft
     Technology Review | Nimbus Discovery is using computational chemistry to drive the drug discovery process.  
    Full story

  • Ignite Institute Finds a Match at Fox Chase

    Jul 18, 2011, 14:40 PM by Michael Croft
    Bio-IT World | Following the demise of plans to locate the Ignite Institute for Individualized Health in Northern Virginia, the institute has found a new home as part of a three-way partnership with Life Technologies at the Fox Chase Cancer Center in Philadelphia.  
    Full story

  • Knome Assists Canadian Team Identify Parkinson’s Disease Gene

    Jul 14, 2011, 11:15 AM by Michael Croft
    Bio-IT World | An international consortium led by researchers at the University of British Columbia (UBC) in Canada, with a major assist from the genome analysis company Knome, have used exome sequencing to identify the sixth known inherited gene defect causing Parkinson’s disease (PD).  
    Full story

  • Updated Accelrys Discovery Studio Targets Protein Aggregation

    Jul 13, 2011, 09:35 AM by Michael Croft
    Bio-IT World | With the latest release of its flagship modeling and simulation software, Discovery Studio, Accelrys is hoping to boost scientific collaboration and efficiency, as well as address a major challenge in the development of biotherapeutics. 
    Full story

  • “Ending Diagnostic Odysseys”: A Bio-IT World Podcast

    Jul 11, 2011, 15:20 PM by Michael Croft

    Bio-IT World | In this exclusive podcast, recorded at the Copenhagenomics conference last month, Liz Worthey (Medical College Wisconsin) discusses the widely publicized case of the clinical genome sequencing of Nicholas Volker, the challenges of data analysis, and how that experience has provided the foundation for ongoing clinical genome sequencing efforts. 

    Full story

  • CLC bio Expands Software Trial for Mini Next-Gen Sequencers

    Jul 7, 2011, 06:45 AM by Michael Croft
    Bio-IT World | Anticipating a flood of new customers for three dynamic new bench top next-gen sequencing instruments, Danish software company CLC bio is extending the trial period for its flagship NGS software product to six months.   
    Full story

  • BGI Announces Cloud Genome Assembly Service

    Jul 6, 2011, 19:10 PM by Michael Croft

    Bio-IT World | SHENZHEN, CHINA—At the BGI Bioinformatics Software Release Conference yesterday, researchers announced two new Cloud-based software-as-a-service offerings for next-gen data analysis. Hecate and Gaea (named for Greek gods) are “flexible computing” solutions for do novo assembly and genome resequencing. 

     

    Full story

  • Ashburner, Troyanskaya Win ISCB Computational Biology Awards

    Jul 5, 2011, 16:00 PM by Michael Croft
    PLoS Computational Biology | The International Society for Computational Biology has given its 2011 senior scientist award to British geneticist Michael Ashburner (University of Cambridge, UK), while the Overton Prize for a young scientist making a significant impact in the field goes to Princeton's Olga Troyanskaya.
    Full story

  • Navigenics Settles Junk DNA Lawsuit with Genetic Technologies

    Jun 29, 2011, 08:55 AM by Michael Croft
    Herald Sun | "Genetic Technologies has brought another large US company to its knees in a drive to stamp its ownership on a type of DNA testing" is how Melbourne's Herald Sun portrays the news of another patent settlement engineered by the Australian firm, this time with personal genomics company Navigenics.
    Full story

  • Lilly Pledges Millions to Biotech

    Jun 29, 2011, 05:00 AM by Michael Croft
    Bloomberg | Yesterday Eli Lilly announced plans to make a mulitmillion-dollar investment in its biotech business, but declined to give a specific number.
    Full story

  • Genomics and Risk

    Jun 29, 2011, 05:00 AM by Michael Croft
    Economist | What do genomics mean for health insurance and equality in health care? Will knowing that you're responsive to a certain drug increase your premiums (you'll live longer, more bills) or decrease them (quicker treatment)?
    Full story

  • Sequencing Devils to Save a Species

    Jun 28, 2011, 12:10 PM by Michael Croft
    USA Today | Scientists from Penn State and the J. Craig Venter Institute have sequenced the genomes of Cedric and Spirit, a pair of Tasmanian Devils, in the hopes of saving the marsupial species that is threatened with extinction due to the rapid spread of an infectious facial cancer.
    Full story

  • Researchers Cry Foul on Ion Torrent License and Inventors’ Rights

    Jun 27, 2011, 13:25 PM by Michael Croft
    Bio-IT World |  A pair of former advisors to Ion Torrent Systems, the semiconductor sequencing company acquired by Life Technologies in a deal potentially worth as much as $725 million, are upset about the exclusive licensing deal negotiated with the company by the Stanford University Office of Technology Licensing, which they say is symptomatic of the mistreatment of academic inventors by their employers. One of those researchers, Nader Pourmand, says his first annual royalty check was just $2,300. 
    Full story

  • HHMI, Max Planck Society and Wellcome Trust Plan Open Access Journal

    Jun 27, 2011, 08:55 AM by Michael Croft

    HHMI News | Three scientific organizations -- the Howard Hughes Medical Institute (HHMI), the Max Planck Society and the Wellcome Trust -- plan to launch a high-impact, open access journal in 2012. The journal will be edited by "experienced and actively actively practicing" scientists who will avoid asking authors to perform endless additional experiments before a paper can be published. 

     

    Full story

  • 23andMe Reports Novel Parkinson's Disease Gene Associations

    Jun 24, 2011, 11:40 AM by Michael Croft
    PLoS Genetics | In a report in the open-access journal PLoS Genetics, researchers at 23andMe studying some 3,500 Parkinson's Disease patients report two novel genome-wide associations with the disease and confirm about 20 others.
    Full story

  • Lilly CEO Lobbies for More Green Cards to Boost Pharma

    Jun 24, 2011, 10:25 AM by Michael Croft
    Bloomberg | The CEO of Eli Lilly, John Lechleiter, says the U.S. Government needs to open its borders and issue more Green Cards to attract and retrain foreign drugmaking research talent. 
    Full story

  • VAAST Potential for New Genome Mutation Hunting Software

    Jun 23, 2011, 11:15 AM by Michael Croft
    Bio-IT World | Scientists at the University of Utah and a Bay Area software company, Omicia, have released details in two new reports of a powerful computational tool called VAAST for identifying disease-causing mutations by individual genome sequencing.
    Full story

  • There's an iPad App for the Human Genome

    Jun 23, 2011, 09:00 AM by Michael Croft
    Researchers from the Center for Biomedical Informatics (CBMi) at The Children’s Hospital of Philadelphia led by Peter White have created a free iPad app called "Genome Wowser," which provides a mobile interface to data from the venerable UC Santa Cruz genome browser. 
    Full story

  • Refer an Software Engineer, Get Your Genome Sequenced

    Jun 23, 2011, 07:25 AM by Michael Croft
    Bio-IT World | In an effort to recruit dozens of top-notch software engineers, a Bay Area software company, DNAnexus, is offering a unique incentive for successful referrals: $20,000 + your full genome sequence.  
    Full story